Sirén AL et al. |
Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats. |
1993 |
Stroke |
pmid:8506560
|
Lindsberg PJ et al. |
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. |
1990 |
Stroke |
pmid:2219210
|
Sirén AL et al. |
Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. |
1992 |
Stroke |
pmid:1440713
|
Joseph R et al. |
Effect of therapy on platelet activating factor-induced aggregation in acute stroke. |
1989 |
Stroke |
pmid:2718200
|
Joseph R and Welch KM |
Granulocytes, platelet activating factor, and stroke. |
1989 |
Stroke |
pmid:2756548
|
Uhl E et al. |
Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application. |
1999 |
Stroke |
pmid:10187894
|
Uhl E et al. |
Influence of platelet-activating factor on cerebral microcirculation in rats: part 2. Local application. |
1999 |
Stroke |
pmid:10187895
|
Bielenberg GW et al. |
Infarct reduction by the platelet activating factor antagonist apafant in rats. |
1992 |
Stroke |
pmid:1731428
|
Joseph R et al. |
Effect of ticlopidine and aspirin on platelet ionized calcium in ischemic stroke. |
1991 |
Stroke |
pmid:2024285
|
Kochanek PM et al. |
Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain. |
1990 |
Stroke |
pmid:2309270
|
Feuerstein G et al. |
Platelet-activating factor. A putative mediator in central nervous system injury? |
1990 |
Stroke |
pmid:2237991
|
Yoshida H et al. |
Platelet-activating factor acetylhydrolase in red cell membranes. Does decreased activity impair erythrocyte deformability in ischemic stroke patients? |
1993 |
Stroke |
pmid:8418541
|
Nishida K and Markey SP |
Platelet-activating factor in brain regions after transient ischemia in gerbils. |
1996 |
Stroke |
pmid:8610322
|
Wei Y et al. |
Structure of a microbial homologue of mammalian platelet-activating factor acetylhydrolases: Streptomyces exfoliatus lipase at 1.9 A resolution. |
1998 |
Structure |
pmid:9562561
|
Anderson BO et al. |
The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. |
1991 |
Surg Gynecol Obstet |
pmid:1851337
|
Biffl WL et al. |
Neutrophil apoptosis is delayed by trauma patients' plasma via a mechanism involving proinflammatory phospholipids and protein kinase C. |
2001 |
Surg Infect (Larchmt) |
pmid:12593704
|
Denham W and Norman J |
The potential role of therapeutic cytokine manipulation in acute pancreatitis. |
1999 |
Surg. Clin. North Am. |
pmid:10470326
|
Fukuoka T et al. |
The platelet activating factor as a pivotal mediator of shock after liver ischemia. |
1995 |
Surg. Today |
pmid:7633127
|
Ono S et al. |
Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC. |
1993 |
Surg. Today |
pmid:8467174
|
Abu-Zidan FM |
Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. |
1998 |
Surgery |
pmid:9481416
|
Yaffe MB et al. |
Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. |
1999 |
Surgery |
pmid:10455891
|
Botha AJ et al. |
Postinjury neutrophil priming and activation: an early vulnerable window. |
1995 |
Surgery |
pmid:7638753
|
Werner J et al. |
Multidrug strategies are effective in the treatment of severe experimental pancreatitis. |
2012 |
Surgery |
pmid:21982067
|
Biffl WL et al. |
Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. |
2003 |
Surgery |
pmid:12874587
|
Unno N et al. |
Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass. |
2002 |
Surgery |
pmid:12110797
|
Partrick DA et al. |
Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway. |
1997 |
Surgery |
pmid:9288123
|
Kim FJ et al. |
Disparate signal transduction in neutrophil CD18 adhesion receptor expression versus superoxide generation. |
1994 |
Surgery |
pmid:8047994
|
Schurr MJ et al. |
Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. |
1997 |
Surgery |
pmid:9142146
|
Takada Y et al. |
Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. |
1998 |
Surgery |
pmid:9626320
|
Porras-Reyes BH and Mustoe TA |
Platelet-activating factor: improvement in wound healing by a chemotactic factor. |
1992 |
Surgery |
pmid:1557687
|
Cuschieri J et al. |
Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. |
2002 |
Surgery |
pmid:12219006
|
Read RA et al. |
Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11b adhesion. |
1993 |
Surgery |
pmid:8342134
|
Liu T et al. |
Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing. |
1990 |
Surgery |
pmid:2237771
|
Wang KS et al. |
Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats. |
1993 |
Surgery |
pmid:8417492
|
Bazan NG and Allan G |
Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids. |
1997 |
Surv Ophthalmol |
pmid:9154273
|
Eser A et al. |
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients. |
2016 |
Taiwan J Obstet Gynecol |
pmid:26927250
|
Miwa M |
[Catabolism of PAF and its regulation]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024018
|
Oda M et al. |
[PAF and diseases]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024019
|
Fukuda T and Makino S |
[Allergy and PAF]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024020
|
Yanoshita R |
[Phospholipid alteration and activation of phospholipase A2 in ischemic heart]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024024
|
Karasawa K and Nojima S |
[Production and application of antibodies to PAF]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024029
|
Tsujimoto M and Hori T |
[Activation of phospholipase A2 by cytokines]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024038
|
Ishii S and Shimizu T |
[Platelet-activating factor (PAF) receptor-related pathophysiology]. |
1999 |
Tanpakushitsu Kakusan Koso |
pmid:10396985
|
Okiji T and Murota S |
[Chemical mediators]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:1901997
|
Mizoguchi H |
[Erythropoietin and thrombopoietin]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:1651533
|
Shindou H and Shimizu T |
[New development of lysophospholipid acyltransferases]. |
2009 |
Tanpakushitsu Kakusan Koso |
pmid:19205351
|
Karasawa K |
[Physiological role of novel metabolic pathway of platelet-activating factor(PAF): PAF-dependent transacetylation]. |
2001 |
Tanpakushitsu Kakusan Koso |
pmid:11193332
|
Masugi F et al. |
[Platelet-activating factor and antihypertensive polar renomedullary lipid: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine]. |
1982 |
Tanpakushitsu Kakusan Koso |
pmid:6758041
|
Terasawa M |
[Platelet-activating factor (PAF) antagonists]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:1850862
|
TatarskiÄ AR et al. |
[Use of plateletpheresis in the treatment of bronchial asthma]. |
1991 |
Ter. Arkh. |
pmid:2063345
|
TatarskiÄ AR and Emirova AS |
[The role of the thrombocytes in the pathogenesis of certain forms of bronchial asthma]. |
1990 |
Ter. Arkh. |
pmid:2142338
|
Skvortsov AA et al. |
[New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy]. |
1989 |
Ter. Arkh. |
pmid:2727928
|
Willerson JT |
Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. |
1995 |
Tex Heart Inst J |
pmid:7787465
|
Desquand S |
[Effects of PAF antagonists in experimental models. Therapeutical perspectives]. |
1993 Nov-Dec |
Therapie |
pmid:8091344
|
Zardini DM and Tschirhart EJ |
[Selective differentiation and proliferation of human eosinophils from umbilical cord blood: calcium fluxes and superoxide ion secretion]. |
1999 Jan-Feb |
Therapie |
pmid:10216433
|
Roudebush WE and Diehl JR |
Platelet-activating factor content in boar spermatozoa correlates with fertility. |
2001 |
Theriogenology |
pmid:11396471
|
O' Meara CM et al. |
Relationship between in vitro sperm functional tests and in vivo fertility of rams following cervical artificial insemination of ewes with frozen-thawed semen. |
2008 |
Theriogenology |
pmid:18248736
|
Bathgate R et al. |
Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters. |
2007 |
Theriogenology |
pmid:17157372
|
Kumar S and Sharma A |
Platelet activating factor improves the in vitro penetration of zona free hamster eggs by buffalo (Bubalus bubalis) spermatozoa. |
2005 |
Theriogenology |
pmid:15763101
|
Shindo K et al. |
Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. |
1997 |
Thorax |
pmid:9516893
|
Chung KF |
Platelet activating factor revisited. |
1997 |
Thorax |
pmid:9516891
|
Shindo K et al. |
Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients. |
1996 |
Thorax |
pmid:8711647
|
McFadden RG et al. |
Effect of platelet activating factor (PAF) on the migration of human lymphocytes. |
1995 |
Thorax |
pmid:7660340
|
Spring J et al. |
Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. |
1992 |
Thorax |
pmid:1361250
|
Chung KF et al. |
Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man. |
1989 |
Thorax |
pmid:2648645
|
Chung KF and Barnes PJ |
Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. |
1989 |
Thorax |
pmid:2648646
|
Summers C et al. |
Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. |
2014 |
Thorax |
pmid:24706039
|
Spencer DA et al. |
Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man. |
1991 |
Thorax |
pmid:1858084
|
Freitag A et al. |
Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. |
1993 |
Thorax |
pmid:8346486
|
Hoenderdos K et al. |
Hypoxia upregulates neutrophil degranulation and potential for tissue injury. |
2016 |
Thorax |
pmid:27581620
|
Alabaster VA and Moore BA |
New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future. |
1993 |
Thorax |
pmid:8493636
|
Moon DG et al. |
Platelet modulation of neutrophil superoxide anion production. |
1990 |
Thromb. Haemost. |
pmid:2160133
|
Nystrom ML et al. |
Platelet shape change in whole blood: differential effects of endotoxin. |
1994 |
Thromb. Haemost. |
pmid:8091394
|
Kavakli K et al. |
Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease. |
1999 |
Thromb. Haemost. |
pmid:10235463
|
Page CP et al. |
An in vivo model for studying platelet aggregation and disaggregation. |
1982 |
Thromb. Haemost. |
pmid:7051409
|
Frelinger AL et al. |
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44. |
2011 |
Thromb. Haemost. |
pmid:21713327
|
Tranquille N and Emeis JJ |
The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor. |
1993 |
Thromb. Haemost. |
pmid:8097063
|
Iyú D et al. |
The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. |
2012 |
Thromb. Haemost. |
pmid:22318645
|
Joseph R et al. |
Sensitivity to PAF is increased in migraine patients. |
1987 |
Thromb. Haemost. |
pmid:3590077
|
Rainger GE et al. |
Neutrophils rolling on immobilised platelets migrate into homotypic aggregates after activation. |
1998 |
Thromb. Haemost. |
pmid:9657445
|
Wal F et al. |
PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin. |
1985 |
Thromb. Haemost. |
pmid:3992525
|
Selak MA |
Neutrophil elastase potentiates cathepsin G-induced platelet activation. |
1992 |
Thromb. Haemost. |
pmid:1333649
|
Smith SV and Brinkhous KM |
Inventory of exogenous platelet-aggregating agent derived from venoms. |
1991 |
Thromb. Haemost. |
pmid:1771620
|
Xavier RG et al. |
Enhanced platelet aggregation and activation under conditions of hypothermia. |
2007 |
Thromb. Haemost. |
pmid:18064324
|
van Giezen JJ et al. |
Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately. |
1994 |
Thromb. Haemost. |
pmid:7740459
|
Handley DA et al. |
Evaluation of dose and route effects of platelet activating factor-induced extravasation in the guinea pig. |
1984 |
Thromb. Haemost. |
pmid:6495262
|
Hermán F et al. |
Decreased sensitivity of platelets to platelet-activating factor in migraine patients during the headache-free interval. |
1989 |
Thromb. Haemost. |
pmid:2814933
|
Mohanty D and Hilgard P |
A new platelet aggregating material (PAM) in an experimentally induced rat fibrosarcoma. |
1984 |
Thromb. Haemost. |
pmid:6740552
|
Iacoviello L et al. |
Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats. |
1995 |
Thromb. Haemost. |
pmid:7482413
|
Sirolli V et al. |
Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. |
2001 |
Thromb. Haemost. |
pmid:11583316
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Montrucchio G et al. |
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. |
2003 |
Thromb. Haemost. |
pmid:14597983
|
Handley DA et al. |
Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig. |
1985 |
Thromb. Haemost. |
pmid:4089809
|
Prescott SM et al. |
The role of platelet-activating factor in endothelial cells. |
1990 |
Thromb. Haemost. |
pmid:2274933
|
Cargill DI et al. |
Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). |
1983 |
Thromb. Haemost. |
pmid:6879508
|
Hermán F et al. |
In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin. |
1991 |
Thromb. Haemost. |
pmid:2048053
|
Chou KJ et al. |
Platelet hyperreactivity in hemodialysis patients with frequently occluded vascular access. |
2004 |
Thromb. Haemost. |
pmid:15351860
|
Ward JR et al. |
Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. |
2005 |
Thromb. Haemost. |
pmid:16270639
|
Satoh K et al. |
Production of platelet-activating factor by porcine brain microvascular endothelial cells in culture. |
1995 |
Thromb. Haemost. |
pmid:8607119
|
Handley DA et al. |
Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441. |
1986 |
Thromb. Haemost. |
pmid:3775689
|